NCT02748993View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

October 31, 2018

Conditions
Atopic Dermatitis
Interventions
DRUG

PAC-14028 Cream 0.1%

Topical application

DRUG

PAC-14028 Cream 0.3%

Topical application

DRUG

PAC-14028 Cream 1.0%

Topical application

DRUG

PAC-14028 Cream Vehicle

Topical application

Trial Locations (3)

Unknown

Chung-ang University Hospital, Seoul

Konkuk University Hospital, Seoul

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02748993 - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis | Biotech Hunter | Biotech Hunter